Suppr超能文献

激素避孕药联合维生素D3补充剂对多囊卵巢综合征女性性功能障碍的影响:一项随机双盲安慰剂对照试验。

The effect of hormonal contraceptives combined with vitamin D3 supplements on sexual dysfunction in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled trial.

作者信息

Jahanian Sadatmahalleh Shahideh, Razavinia Fatemeh, Lotfi Razieh, Hajimoosayi Fariba, Nasiri Malihe, Rezasoltani Parvaneh

机构信息

Department of Reproductive Health and Midwifery, Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Jalal Al-Ahmad HighwayNasr Bridge, Tehran, 14115-111, Iran.

Sexual And Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Arch Gynecol Obstet. 2025 Sep 6. doi: 10.1007/s00404-025-08159-4.

Abstract

BACKGROUND

Polycystic ovary syndrome (PCOS) is characterized by reproductive and endocrine abnormalities.

OBJECTIVE

The present study aimed to assess the effect of oral contraceptive pills (OCPs) and vitamin D3 on sexual dysfunction in women with PCOS and vitamin D3 deficiency.

MATERIALS AND METHODS

This randomized double-blind placebo-controlled clinical trial was conducted in Iran between January and April 2019. The Female Sexual Function Index (FSFI) and Beck Depression Inventory (BDI) questionnaires were filled out for all participants and their serum levels of vitamin D3 were measured. Women with PCOS and vitamin D3 deficiency were divided into 2 equal groups (A and B) with a table of random numbers (n = 35/ each). Both groups were given vitamin D3 (50,000 IU/w) for 12 week. The case group was given low-dose OCP for 3 months and a similar placebo was given to the control group. Vitamin D3 level and sexual function were assessed in both groups at 3 and 6 months after taking OCP.

RESULTS

There was no statistically significant difference between the two groups in demographic characteristic such as weight (69.54 ± 10.34 vs 70.17 ± 10.60, P = 0.803). Both groups treated with vitamin D3 exhibited increased sexual function scores at the beginning of the study (P = 0.03) and 3 months (P = 0.01) after taking OCP. Examination of sexual function variables showed that sexual desire in the control group was greater than in the OCP-treated group at 3 (P = 0.009) and 6 (P = 0.01) months after entering the study.

CONCLUSION

The results of the study showed that the score of women's sexual performance increased in all areas, especially in the area of sexual desire, with the use of vitamin D3. The simultaneous use of OCP with vitamin D3 to improve sexual performance in these women had no significant difference with the use of vitamin D3 alone. According to the research findings, it is recommended that vitamin D3 supplementation can be used to increase the quality of life and improve sexual function in PCOS women.

摘要

背景

多囊卵巢综合征(PCOS)的特征是生殖和内分泌异常。

目的

本研究旨在评估口服避孕药(OCPs)和维生素D3对患有PCOS且维生素D3缺乏的女性性功能障碍的影响。

材料与方法

这项随机双盲安慰剂对照临床试验于2019年1月至4月在伊朗进行。为所有参与者填写女性性功能指数(FSFI)和贝克抑郁量表(BDI)问卷,并测量其血清维生素D3水平。患有PCOS且维生素D3缺乏的女性通过随机数字表分为2个相等的组(A组和B组)(每组n = 35)。两组均给予维生素D3(50,000 IU/周),持续12周。病例组给予低剂量OCP 3个月,对照组给予类似的安慰剂。在服用OCP后3个月和6个月时评估两组的维生素D3水平和性功能。

结果

两组在体重等人口统计学特征方面无统计学显著差异(69.54±10.34 vs 70.17±10.60,P = 0.803)。两组在服用OCP后的研究开始时(P = 0.03)和3个月时(P = 0.01)性功能评分均有所提高。性功能变量检查显示,在进入研究后的3个月(P = 0.009)和6个月(P = 0.01)时,对照组的性欲高于OCP治疗组。

结论

研究结果表明,使用维生素D3后,女性性功能在所有方面的评分均有所提高,尤其是在性欲方面。同时使用OCP和维生素D3来改善这些女性的性功能与单独使用维生素D3相比无显著差异。根据研究结果,建议补充维生素D3可用于提高PCOS女性的生活质量并改善其性功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验